Conserved Angio-Immune Subtypes of the Tumor Microenvironment Predict Response to Immune Checkpoint Blockade Therapy

The authors classified the tumor microenvironment (TME) by analyzing the transcriptome from 11,069 cancer patients based on angiogenesis and T cell activity, and found three distinct angio-immune TME subtypes conserved across 30 non-hematological cancers.